Publications by Dr Miranda Morton - ePrints

Browsing publications by Dr Miranda Morton.

Newcastle Authors	Title	Year
Dr Arthur Pratt Dr Stefan Siebert Mike Cole Dr Deborah Stocken Amy Cranston et al.	Targeting synovial fibroblast proliferation in rheumatoid arthritis (TRAFIC): an open-label, dose-finding, phase 1b trial	2021
Dr Stefan Siebert Dr Arthur Pratt Dr Deborah Stocken Dr Miranda Morton Amy Cranston et al.	Targeting the rheumatoid arthritis synovial fibroblast via cyclin dependent kinase inhibition: An early phase trial	2020
Dr Emma Clark Dr Miranda Morton Shriya Sharma Dr Holly Fisher Denise Howel et al.	Prostate cancer androgen receptor splice variant 7 biomarker study - A multicentre randomised feasibility trial of biomarker-guided personalised treatment in patients with advanced prostate cancer (the VARIANT trial) study protocol	2019
Dr Ashleigh Herriott Dr Miranda Morton Professor Nicola Curtin	Phase I, dose-escalation, two-part trial of the PARP inhibitor talazoparib in patients with advanced germline BRCA1/2 mutations and selected sporadic cancers	2017
Iaroslava Kos Dr Miranda Morton Alessandra da Silva Dantas Professor Janet Quinn	Mechanisms underlying the delayed activation of the Cap1 transcription factor in Candida albicans following combinatorial oxidative and cationic stress important for phagocytic potency	2016
Dr Alastair Greystoke Dr Linda Hogarth Dr Miranda Morton Liam Bolt Dianne Turner et al.	The introduction of the Cancer Research UK Stratified Medicine Programme 2 (CRUK SMP2) in North East England; lessons learned and experience gained	2016
Fiona Middleton Dr Miranda Morton Dr Claire Elstob Dr Sarah Fordham Dr Ashleigh Herriott et al.	Common cancer-associated imbalances in the DNA damage response confer sensitivity to single agent ATR inhibition	2015
Dr Ashleigh Herriott Dr Susan Tudhope Gesa Junge Natalie Rodrigues Dr Miranda Morton et al.	PARP1 expression, activity and ex vivo sensitivity to the PARP inhibitor, talazoparib (BMN 673), in Chronic Lymphocytic Leukaemia	2015
Dr Miranda Morton Dr Ian Forrest Becci Sharrock Maria Lane Dr Angelika Kaufmann et al.	Assessing the function of homologous recombination DNA repair in malignant pleural effusion (MPE) samples	2014
Dr Miranda Morton Professor Janet Quinn	Mechanisms Underlying the Exquisite Sensitivity of Candida albicans to Combinatorial Cationic and Oxidative Stress That Enhances the Potent Fungicidal Activity of Phagocytes	2014
James Murray Huw Thomas Philip Berry Suzanne Kyle Dr Miranda Morton et al.	Tumour cell retention of rucaparib, sustained PARP inhibition and efficacy of weekly as well as daily schedules	2014
Dr Miranda Morton Professor Nicola Curtin	Microsatellite instability induced mutations in DNA repair genes CtIP and MRE11 confer hypersensitivity to poly (ADP-ribose) polymerase inhibitors in myeloid malignancies	2013
Dr Miranda Morton Alessandra da Silva Dantas Dr Elizabeth Veal Professor Brian Morgan Professor Janet Quinn et al.	Ybp1 and Gpx3 Signaling in Candida albicans Govern Hydrogen Peroxide-Induced Oxidation of the Cap1 Transcription Factor and Macrophage Escape	2013
Dr Miranda Morton Professor Janet Quinn	Impact of combinatorial stresses upon Candida albicans	2012
Dr Miranda Morton James Murray Professor Nicola Curtin	Stability of PARP Inhibition by BMN 673 in Human PBMCs (and Leukaemic Cell Cultures)	2012
Alessandra da Silva Dantas Dr Miranda Morton Professor Brian Morgan Professor Janet Quinn	Thioredoxin regulates multiple hydrogen peroxide-induced signaling pathways in Candida albicans	2010
Jill Cheetham Alessandra da Silva Dantas Dr Miranda Morton Dr Catherine Bruce Professor Janet Quinn et al.	A single MAPKKK regulates the Hog1 MAPK pathway in the pathogenic fungus Candida albicans	2007